Global Nuclear Medicine Imaging Agents Market Growth 2026-2032
The global Nuclear Medicine Imaging Agents market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Nuclear Medicine Imaging Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Nuclear Medicine Imaging Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Nuclear Medicine Imaging Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Nuclear Medicine Imaging Agents players cover GE HealthCare, Bracco Diagnostic, Guerbet, Mallinckrodt, Lantheus, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Nuclear Medicine Imaging Agents Industry Forecast” looks at past sales and reviews total world Nuclear Medicine Imaging Agents sales in 2025, providing a comprehensive analysis by region and market sector of projected Nuclear Medicine Imaging Agents sales for 2026 through 2032. With Nuclear Medicine Imaging Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Medicine Imaging Agents industry.
This Insight Report provides a comprehensive analysis of the global Nuclear Medicine Imaging Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nuclear Medicine Imaging Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nuclear Medicine Imaging Agents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Medicine Imaging Agents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Medicine Imaging Agents.
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine Imaging Agents market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Nuclear Medicine Imaging Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Nuclear Medicine Imaging Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Nuclear Medicine Imaging Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Nuclear Medicine Imaging Agents players cover GE HealthCare, Bracco Diagnostic, Guerbet, Mallinckrodt, Lantheus, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Nuclear Medicine Imaging Agents Industry Forecast” looks at past sales and reviews total world Nuclear Medicine Imaging Agents sales in 2025, providing a comprehensive analysis by region and market sector of projected Nuclear Medicine Imaging Agents sales for 2026 through 2032. With Nuclear Medicine Imaging Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Medicine Imaging Agents industry.
This Insight Report provides a comprehensive analysis of the global Nuclear Medicine Imaging Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nuclear Medicine Imaging Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nuclear Medicine Imaging Agents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Medicine Imaging Agents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Medicine Imaging Agents.
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine Imaging Agents market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Fluorine 18 Labeling
- Carbon 11 Labeling
- Nitrogen 13 Labeling
- Oxygen 15 Labeling
- Technetium 99 Labeling
- Others
- Early Diagnosis
- Clinical Stage
- Treatment Evaluation
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GE HealthCare
- Bracco Diagnostic
- Guerbet
- Mallinckrodt
- Lantheus
- Yantai Dongcheng
- Foshan Rui Diao Pharmaceutical
- Cardinal Health
- Blue Earth Diagnostics
- Bayer AG
- Abx Advanced Biochemical
- Eli Lilly and Company
- Jubilant Pharma Limited
- Navidea
- What is the 10-year outlook for the global Nuclear Medicine Imaging Agents market?
- What factors are driving Nuclear Medicine Imaging Agents market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Nuclear Medicine Imaging Agents market opportunities vary by end market size?
- How does Nuclear Medicine Imaging Agents break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclear Medicine Imaging Agents Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Nuclear Medicine Imaging Agents by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Nuclear Medicine Imaging Agents by Country/Region, 2021, 2025 & 2032
2.2 Nuclear Medicine Imaging Agents Segment by Type
2.2.1 Fluorine 18 Labeling
2.2.2 Carbon 11 Labeling
2.2.3 Nitrogen 13 Labeling
2.2.4 Oxygen 15 Labeling
2.2.5 Technetium 99 Labeling
2.2.6 Others
2.2.7 Nuclear Medicine Imaging Agents Sales by Type
2.2.7.1 Global Nuclear Medicine Imaging Agents Sales Market Share by Type (2021-2026)
2.2.7.2 Global Nuclear Medicine Imaging Agents Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Nuclear Medicine Imaging Agents Sale Price by Type (2021-2026)
2.3 Nuclear Medicine Imaging Agents Segment by Application
2.3.1 Early Diagnosis
2.3.2 Clinical Stage
2.3.3 Treatment Evaluation
2.3.4 Nuclear Medicine Imaging Agents Sales by Application
2.3.4.1 Global Nuclear Medicine Imaging Agents Sale Market Share by Application (2021-2026)
2.3.4.2 Global Nuclear Medicine Imaging Agents Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Nuclear Medicine Imaging Agents Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Nuclear Medicine Imaging Agents Breakdown Data by Company
3.1.1 Global Nuclear Medicine Imaging Agents Annual Sales by Company (2021-2026)
3.1.2 Global Nuclear Medicine Imaging Agents Sales Market Share by Company (2021-2026)
3.2 Global Nuclear Medicine Imaging Agents Annual Revenue by Company (2021-2026)
3.2.1 Global Nuclear Medicine Imaging Agents Revenue by Company (2021-2026)
3.2.2 Global Nuclear Medicine Imaging Agents Revenue Market Share by Company (2021-2026)
3.3 Global Nuclear Medicine Imaging Agents Sale Price by Company
3.4 Key Manufacturers Nuclear Medicine Imaging Agents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nuclear Medicine Imaging Agents Product Location Distribution
3.4.2 Players Nuclear Medicine Imaging Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NUCLEAR MEDICINE IMAGING AGENTS BY GEOGRAPHIC REGION
4.1 World Historic Nuclear Medicine Imaging Agents Market Size by Geographic Region (2021-2026)
4.1.1 Global Nuclear Medicine Imaging Agents Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Nuclear Medicine Imaging Agents Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Nuclear Medicine Imaging Agents Market Size by Country/Region (2021-2026)
4.2.1 Global Nuclear Medicine Imaging Agents Annual Sales by Country/Region (2021-2026)
4.2.2 Global Nuclear Medicine Imaging Agents Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nuclear Medicine Imaging Agents Sales Growth
4.4 APAC Nuclear Medicine Imaging Agents Sales Growth
4.5 Europe Nuclear Medicine Imaging Agents Sales Growth
4.6 Middle East & Africa Nuclear Medicine Imaging Agents Sales Growth
5 AMERICAS
5.1 Americas Nuclear Medicine Imaging Agents Sales by Country
5.1.1 Americas Nuclear Medicine Imaging Agents Sales by Country (2021-2026)
5.1.2 Americas Nuclear Medicine Imaging Agents Revenue by Country (2021-2026)
5.2 Americas Nuclear Medicine Imaging Agents Sales by Type (2021-2026)
5.3 Americas Nuclear Medicine Imaging Agents Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Medicine Imaging Agents Sales by Region
6.1.1 APAC Nuclear Medicine Imaging Agents Sales by Region (2021-2026)
6.1.2 APAC Nuclear Medicine Imaging Agents Revenue by Region (2021-2026)
6.2 APAC Nuclear Medicine Imaging Agents Sales by Type (2021-2026)
6.3 APAC Nuclear Medicine Imaging Agents Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nuclear Medicine Imaging Agents by Country
7.1.1 Europe Nuclear Medicine Imaging Agents Sales by Country (2021-2026)
7.1.2 Europe Nuclear Medicine Imaging Agents Revenue by Country (2021-2026)
7.2 Europe Nuclear Medicine Imaging Agents Sales by Type (2021-2026)
7.3 Europe Nuclear Medicine Imaging Agents Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclear Medicine Imaging Agents by Country
8.1.1 Middle East & Africa Nuclear Medicine Imaging Agents Sales by Country (2021-2026)
8.1.2 Middle East & Africa Nuclear Medicine Imaging Agents Revenue by Country (2021-2026)
8.2 Middle East & Africa Nuclear Medicine Imaging Agents Sales by Type (2021-2026)
8.3 Middle East & Africa Nuclear Medicine Imaging Agents Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nuclear Medicine Imaging Agents
10.3 Manufacturing Process Analysis of Nuclear Medicine Imaging Agents
10.4 Industry Chain Structure of Nuclear Medicine Imaging Agents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nuclear Medicine Imaging Agents Distributors
11.3 Nuclear Medicine Imaging Agents Customer
12 WORLD FORECAST REVIEW FOR NUCLEAR MEDICINE IMAGING AGENTS BY GEOGRAPHIC REGION
12.1 Global Nuclear Medicine Imaging Agents Market Size Forecast by Region
12.1.1 Global Nuclear Medicine Imaging Agents Forecast by Region (2027-2032)
12.1.2 Global Nuclear Medicine Imaging Agents Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Nuclear Medicine Imaging Agents Forecast by Type (2027-2032)
12.7 Global Nuclear Medicine Imaging Agents Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GE HealthCare
13.1.1 GE HealthCare Company Information
13.1.2 GE HealthCare Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.1.3 GE HealthCare Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GE HealthCare Main Business Overview
13.1.5 GE HealthCare Latest Developments
13.2 Bracco Diagnostic
13.2.1 Bracco Diagnostic Company Information
13.2.2 Bracco Diagnostic Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.2.3 Bracco Diagnostic Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Bracco Diagnostic Main Business Overview
13.2.5 Bracco Diagnostic Latest Developments
13.3 Guerbet
13.3.1 Guerbet Company Information
13.3.2 Guerbet Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.3.3 Guerbet Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Guerbet Main Business Overview
13.3.5 Guerbet Latest Developments
13.4 Mallinckrodt
13.4.1 Mallinckrodt Company Information
13.4.2 Mallinckrodt Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.4.3 Mallinckrodt Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Mallinckrodt Main Business Overview
13.4.5 Mallinckrodt Latest Developments
13.5 Lantheus
13.5.1 Lantheus Company Information
13.5.2 Lantheus Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.5.3 Lantheus Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Lantheus Main Business Overview
13.5.5 Lantheus Latest Developments
13.6 Yantai Dongcheng
13.6.1 Yantai Dongcheng Company Information
13.6.2 Yantai Dongcheng Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.6.3 Yantai Dongcheng Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Yantai Dongcheng Main Business Overview
13.6.5 Yantai Dongcheng Latest Developments
13.7 Foshan Rui Diao Pharmaceutical
13.7.1 Foshan Rui Diao Pharmaceutical Company Information
13.7.2 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.7.3 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Foshan Rui Diao Pharmaceutical Main Business Overview
13.7.5 Foshan Rui Diao Pharmaceutical Latest Developments
13.8 Cardinal Health
13.8.1 Cardinal Health Company Information
13.8.2 Cardinal Health Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.8.3 Cardinal Health Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Cardinal Health Main Business Overview
13.8.5 Cardinal Health Latest Developments
13.9 Blue Earth Diagnostics
13.9.1 Blue Earth Diagnostics Company Information
13.9.2 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.9.3 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Blue Earth Diagnostics Main Business Overview
13.9.5 Blue Earth Diagnostics Latest Developments
13.10 Bayer AG
13.10.1 Bayer AG Company Information
13.10.2 Bayer AG Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.10.3 Bayer AG Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Bayer AG Main Business Overview
13.10.5 Bayer AG Latest Developments
13.11 Abx Advanced Biochemical
13.11.1 Abx Advanced Biochemical Company Information
13.11.2 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.11.3 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Abx Advanced Biochemical Main Business Overview
13.11.5 Abx Advanced Biochemical Latest Developments
13.12 Eli Lilly and Company
13.12.1 Eli Lilly and Company Company Information
13.12.2 Eli Lilly and Company Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.12.3 Eli Lilly and Company Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Eli Lilly and Company Main Business Overview
13.12.5 Eli Lilly and Company Latest Developments
13.13 Jubilant Pharma Limited
13.13.1 Jubilant Pharma Limited Company Information
13.13.2 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.13.3 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Jubilant Pharma Limited Main Business Overview
13.13.5 Jubilant Pharma Limited Latest Developments
13.14 Navidea
13.14.1 Navidea Company Information
13.14.2 Navidea Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.14.3 Navidea Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Navidea Main Business Overview
13.14.5 Navidea Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclear Medicine Imaging Agents Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Nuclear Medicine Imaging Agents by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Nuclear Medicine Imaging Agents by Country/Region, 2021, 2025 & 2032
2.2 Nuclear Medicine Imaging Agents Segment by Type
2.2.1 Fluorine 18 Labeling
2.2.2 Carbon 11 Labeling
2.2.3 Nitrogen 13 Labeling
2.2.4 Oxygen 15 Labeling
2.2.5 Technetium 99 Labeling
2.2.6 Others
2.2.7 Nuclear Medicine Imaging Agents Sales by Type
2.2.7.1 Global Nuclear Medicine Imaging Agents Sales Market Share by Type (2021-2026)
2.2.7.2 Global Nuclear Medicine Imaging Agents Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Nuclear Medicine Imaging Agents Sale Price by Type (2021-2026)
2.3 Nuclear Medicine Imaging Agents Segment by Application
2.3.1 Early Diagnosis
2.3.2 Clinical Stage
2.3.3 Treatment Evaluation
2.3.4 Nuclear Medicine Imaging Agents Sales by Application
2.3.4.1 Global Nuclear Medicine Imaging Agents Sale Market Share by Application (2021-2026)
2.3.4.2 Global Nuclear Medicine Imaging Agents Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Nuclear Medicine Imaging Agents Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Nuclear Medicine Imaging Agents Breakdown Data by Company
3.1.1 Global Nuclear Medicine Imaging Agents Annual Sales by Company (2021-2026)
3.1.2 Global Nuclear Medicine Imaging Agents Sales Market Share by Company (2021-2026)
3.2 Global Nuclear Medicine Imaging Agents Annual Revenue by Company (2021-2026)
3.2.1 Global Nuclear Medicine Imaging Agents Revenue by Company (2021-2026)
3.2.2 Global Nuclear Medicine Imaging Agents Revenue Market Share by Company (2021-2026)
3.3 Global Nuclear Medicine Imaging Agents Sale Price by Company
3.4 Key Manufacturers Nuclear Medicine Imaging Agents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nuclear Medicine Imaging Agents Product Location Distribution
3.4.2 Players Nuclear Medicine Imaging Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NUCLEAR MEDICINE IMAGING AGENTS BY GEOGRAPHIC REGION
4.1 World Historic Nuclear Medicine Imaging Agents Market Size by Geographic Region (2021-2026)
4.1.1 Global Nuclear Medicine Imaging Agents Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Nuclear Medicine Imaging Agents Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Nuclear Medicine Imaging Agents Market Size by Country/Region (2021-2026)
4.2.1 Global Nuclear Medicine Imaging Agents Annual Sales by Country/Region (2021-2026)
4.2.2 Global Nuclear Medicine Imaging Agents Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nuclear Medicine Imaging Agents Sales Growth
4.4 APAC Nuclear Medicine Imaging Agents Sales Growth
4.5 Europe Nuclear Medicine Imaging Agents Sales Growth
4.6 Middle East & Africa Nuclear Medicine Imaging Agents Sales Growth
5 AMERICAS
5.1 Americas Nuclear Medicine Imaging Agents Sales by Country
5.1.1 Americas Nuclear Medicine Imaging Agents Sales by Country (2021-2026)
5.1.2 Americas Nuclear Medicine Imaging Agents Revenue by Country (2021-2026)
5.2 Americas Nuclear Medicine Imaging Agents Sales by Type (2021-2026)
5.3 Americas Nuclear Medicine Imaging Agents Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Medicine Imaging Agents Sales by Region
6.1.1 APAC Nuclear Medicine Imaging Agents Sales by Region (2021-2026)
6.1.2 APAC Nuclear Medicine Imaging Agents Revenue by Region (2021-2026)
6.2 APAC Nuclear Medicine Imaging Agents Sales by Type (2021-2026)
6.3 APAC Nuclear Medicine Imaging Agents Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nuclear Medicine Imaging Agents by Country
7.1.1 Europe Nuclear Medicine Imaging Agents Sales by Country (2021-2026)
7.1.2 Europe Nuclear Medicine Imaging Agents Revenue by Country (2021-2026)
7.2 Europe Nuclear Medicine Imaging Agents Sales by Type (2021-2026)
7.3 Europe Nuclear Medicine Imaging Agents Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclear Medicine Imaging Agents by Country
8.1.1 Middle East & Africa Nuclear Medicine Imaging Agents Sales by Country (2021-2026)
8.1.2 Middle East & Africa Nuclear Medicine Imaging Agents Revenue by Country (2021-2026)
8.2 Middle East & Africa Nuclear Medicine Imaging Agents Sales by Type (2021-2026)
8.3 Middle East & Africa Nuclear Medicine Imaging Agents Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nuclear Medicine Imaging Agents
10.3 Manufacturing Process Analysis of Nuclear Medicine Imaging Agents
10.4 Industry Chain Structure of Nuclear Medicine Imaging Agents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nuclear Medicine Imaging Agents Distributors
11.3 Nuclear Medicine Imaging Agents Customer
12 WORLD FORECAST REVIEW FOR NUCLEAR MEDICINE IMAGING AGENTS BY GEOGRAPHIC REGION
12.1 Global Nuclear Medicine Imaging Agents Market Size Forecast by Region
12.1.1 Global Nuclear Medicine Imaging Agents Forecast by Region (2027-2032)
12.1.2 Global Nuclear Medicine Imaging Agents Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Nuclear Medicine Imaging Agents Forecast by Type (2027-2032)
12.7 Global Nuclear Medicine Imaging Agents Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GE HealthCare
13.1.1 GE HealthCare Company Information
13.1.2 GE HealthCare Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.1.3 GE HealthCare Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GE HealthCare Main Business Overview
13.1.5 GE HealthCare Latest Developments
13.2 Bracco Diagnostic
13.2.1 Bracco Diagnostic Company Information
13.2.2 Bracco Diagnostic Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.2.3 Bracco Diagnostic Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Bracco Diagnostic Main Business Overview
13.2.5 Bracco Diagnostic Latest Developments
13.3 Guerbet
13.3.1 Guerbet Company Information
13.3.2 Guerbet Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.3.3 Guerbet Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Guerbet Main Business Overview
13.3.5 Guerbet Latest Developments
13.4 Mallinckrodt
13.4.1 Mallinckrodt Company Information
13.4.2 Mallinckrodt Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.4.3 Mallinckrodt Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Mallinckrodt Main Business Overview
13.4.5 Mallinckrodt Latest Developments
13.5 Lantheus
13.5.1 Lantheus Company Information
13.5.2 Lantheus Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.5.3 Lantheus Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Lantheus Main Business Overview
13.5.5 Lantheus Latest Developments
13.6 Yantai Dongcheng
13.6.1 Yantai Dongcheng Company Information
13.6.2 Yantai Dongcheng Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.6.3 Yantai Dongcheng Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Yantai Dongcheng Main Business Overview
13.6.5 Yantai Dongcheng Latest Developments
13.7 Foshan Rui Diao Pharmaceutical
13.7.1 Foshan Rui Diao Pharmaceutical Company Information
13.7.2 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.7.3 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Foshan Rui Diao Pharmaceutical Main Business Overview
13.7.5 Foshan Rui Diao Pharmaceutical Latest Developments
13.8 Cardinal Health
13.8.1 Cardinal Health Company Information
13.8.2 Cardinal Health Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.8.3 Cardinal Health Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Cardinal Health Main Business Overview
13.8.5 Cardinal Health Latest Developments
13.9 Blue Earth Diagnostics
13.9.1 Blue Earth Diagnostics Company Information
13.9.2 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.9.3 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Blue Earth Diagnostics Main Business Overview
13.9.5 Blue Earth Diagnostics Latest Developments
13.10 Bayer AG
13.10.1 Bayer AG Company Information
13.10.2 Bayer AG Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.10.3 Bayer AG Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Bayer AG Main Business Overview
13.10.5 Bayer AG Latest Developments
13.11 Abx Advanced Biochemical
13.11.1 Abx Advanced Biochemical Company Information
13.11.2 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.11.3 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Abx Advanced Biochemical Main Business Overview
13.11.5 Abx Advanced Biochemical Latest Developments
13.12 Eli Lilly and Company
13.12.1 Eli Lilly and Company Company Information
13.12.2 Eli Lilly and Company Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.12.3 Eli Lilly and Company Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Eli Lilly and Company Main Business Overview
13.12.5 Eli Lilly and Company Latest Developments
13.13 Jubilant Pharma Limited
13.13.1 Jubilant Pharma Limited Company Information
13.13.2 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.13.3 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Jubilant Pharma Limited Main Business Overview
13.13.5 Jubilant Pharma Limited Latest Developments
13.14 Navidea
13.14.1 Navidea Company Information
13.14.2 Navidea Nuclear Medicine Imaging Agents Product Portfolios and Specifications
13.14.3 Navidea Nuclear Medicine Imaging Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Navidea Main Business Overview
13.14.5 Navidea Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nuclear Medicine Imaging Agents Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Nuclear Medicine Imaging Agents Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Fluorine 18 Labeling
Table 4. Major Players of Carbon 11 Labeling
Table 5. Major Players of Nitrogen 13 Labeling
Table 6. Major Players of Oxygen 15 Labeling
Table 7. Major Players of Technetium 99 Labeling
Table 8. Major Players of Others
Table 9. Global Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units)
Table 10. Global Nuclear Medicine Imaging Agents Sales Market Share by Type (2021-2026)
Table 11. Global Nuclear Medicine Imaging Agents Revenue by Type (2021-2026) & ($ million)
Table 12. Global Nuclear Medicine Imaging Agents Revenue Market Share by Type (2021-2026)
Table 13. Global Nuclear Medicine Imaging Agents Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Global Nuclear Medicine Imaging Agents Sale by Application (2021-2026) & (K Units)
Table 15. Global Nuclear Medicine Imaging Agents Sale Market Share by Application (2021-2026)
Table 16. Global Nuclear Medicine Imaging Agents Revenue by Application (2021-2026) & ($ million)
Table 17. Global Nuclear Medicine Imaging Agents Revenue Market Share by Application (2021-2026)
Table 18. Global Nuclear Medicine Imaging Agents Sale Price by Application (2021-2026) & (US$/Unit)
Table 19. Global Nuclear Medicine Imaging Agents Sales by Company (2021-2026) & (K Units)
Table 20. Global Nuclear Medicine Imaging Agents Sales Market Share by Company (2021-2026)
Table 21. Global Nuclear Medicine Imaging Agents Revenue by Company (2021-2026) & ($ millions)
Table 22. Global Nuclear Medicine Imaging Agents Revenue Market Share by Company (2021-2026)
Table 23. Global Nuclear Medicine Imaging Agents Sale Price by Company (2021-2026) & (US$/Unit)
Table 24. Key Manufacturers Nuclear Medicine Imaging Agents Producing Area Distribution and Sales Area
Table 25. Players Nuclear Medicine Imaging Agents Products Offered
Table 26. Nuclear Medicine Imaging Agents Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Nuclear Medicine Imaging Agents Sales by Geographic Region (2021-2026) & (K Units)
Table 30. Global Nuclear Medicine Imaging Agents Sales Market Share Geographic Region (2021-2026)
Table 31. Global Nuclear Medicine Imaging Agents Revenue by Geographic Region (2021-2026) & ($ millions)
Table 32. Global Nuclear Medicine Imaging Agents Revenue Market Share by Geographic Region (2021-2026)
Table 33. Global Nuclear Medicine Imaging Agents Sales by Country/Region (2021-2026) & (K Units)
Table 34. Global Nuclear Medicine Imaging Agents Sales Market Share by Country/Region (2021-2026)
Table 35. Global Nuclear Medicine Imaging Agents Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Nuclear Medicine Imaging Agents Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Nuclear Medicine Imaging Agents Sales by Country (2021-2026) & (K Units)
Table 38. Americas Nuclear Medicine Imaging Agents Sales Market Share by Country (2021-2026)
Table 39. Americas Nuclear Medicine Imaging Agents Revenue by Country (2021-2026) & ($ millions)
Table 40. Americas Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units)
Table 41. Americas Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (K Units)
Table 42. APAC Nuclear Medicine Imaging Agents Sales by Region (2021-2026) & (K Units)
Table 43. APAC Nuclear Medicine Imaging Agents Sales Market Share by Region (2021-2026)
Table 44. APAC Nuclear Medicine Imaging Agents Revenue by Region (2021-2026) & ($ millions)
Table 45. APAC Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units)
Table 46. APAC Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (K Units)
Table 47. Europe Nuclear Medicine Imaging Agents Sales by Country (2021-2026) & (K Units)
Table 48. Europe Nuclear Medicine Imaging Agents Revenue by Country (2021-2026) & ($ millions)
Table 49. Europe Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units)
Table 50. Europe Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (K Units)
Table 51. Middle East & Africa Nuclear Medicine Imaging Agents Sales by Country (2021-2026) & (K Units)
Table 52. Middle East & Africa Nuclear Medicine Imaging Agents Revenue Market Share by Country (2021-2026)
Table 53. Middle East & Africa Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units)
Table 54. Middle East & Africa Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Nuclear Medicine Imaging Agents
Table 56. Key Market Challenges & Risks of Nuclear Medicine Imaging Agents
Table 57. Key Industry Trends of Nuclear Medicine Imaging Agents
Table 58. Nuclear Medicine Imaging Agents Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Nuclear Medicine Imaging Agents Distributors List
Table 61. Nuclear Medicine Imaging Agents Customer List
Table 62. Global Nuclear Medicine Imaging Agents Sales Forecast by Region (2027-2032) & (K Units)
Table 63. Global Nuclear Medicine Imaging Agents Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Americas Nuclear Medicine Imaging Agents Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Americas Nuclear Medicine Imaging Agents Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. APAC Nuclear Medicine Imaging Agents Sales Forecast by Region (2027-2032) & (K Units)
Table 67. APAC Nuclear Medicine Imaging Agents Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Europe Nuclear Medicine Imaging Agents Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Europe Nuclear Medicine Imaging Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Middle East & Africa Nuclear Medicine Imaging Agents Sales Forecast by Country (2027-2032) & (K Units)
Table 71. Middle East & Africa Nuclear Medicine Imaging Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. Global Nuclear Medicine Imaging Agents Sales Forecast by Type (2027-2032) & (K Units)
Table 73. Global Nuclear Medicine Imaging Agents Revenue Forecast by Type (2027-2032) & ($ millions)
Table 74. Global Nuclear Medicine Imaging Agents Sales Forecast by Application (2027-2032) & (K Units)
Table 75. Global Nuclear Medicine Imaging Agents Revenue Forecast by Application (2027-2032) & ($ millions)
Table 76. GE HealthCare Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 77. GE HealthCare Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 78. GE HealthCare Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 79. GE HealthCare Main Business
Table 80. GE HealthCare Latest Developments
Table 81. Bracco Diagnostic Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 82. Bracco Diagnostic Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 83. Bracco Diagnostic Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. Bracco Diagnostic Main Business
Table 85. Bracco Diagnostic Latest Developments
Table 86. Guerbet Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 87. Guerbet Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 88. Guerbet Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Guerbet Main Business
Table 90. Guerbet Latest Developments
Table 91. Mallinckrodt Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 92. Mallinckrodt Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 93. Mallinckrodt Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Mallinckrodt Main Business
Table 95. Mallinckrodt Latest Developments
Table 96. Lantheus Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 97. Lantheus Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 98. Lantheus Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Lantheus Main Business
Table 100. Lantheus Latest Developments
Table 101. Yantai Dongcheng Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 102. Yantai Dongcheng Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 103. Yantai Dongcheng Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Yantai Dongcheng Main Business
Table 105. Yantai Dongcheng Latest Developments
Table 106. Foshan Rui Diao Pharmaceutical Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 107. Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 108. Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Foshan Rui Diao Pharmaceutical Main Business
Table 110. Foshan Rui Diao Pharmaceutical Latest Developments
Table 111. Cardinal Health Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 112. Cardinal Health Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 113. Cardinal Health Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Cardinal Health Main Business
Table 115. Cardinal Health Latest Developments
Table 116. Blue Earth Diagnostics Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 117. Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 118. Blue Earth Diagnostics Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Blue Earth Diagnostics Main Business
Table 120. Blue Earth Diagnostics Latest Developments
Table 121. Bayer AG Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 122. Bayer AG Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 123. Bayer AG Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Bayer AG Main Business
Table 125. Bayer AG Latest Developments
Table 126. Abx Advanced Biochemical Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 127. Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 128. Abx Advanced Biochemical Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. Abx Advanced Biochemical Main Business
Table 130. Abx Advanced Biochemical Latest Developments
Table 131. Eli Lilly and Company Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 132. Eli Lilly and Company Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 133. Eli Lilly and Company Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. Eli Lilly and Company Main Business
Table 135. Eli Lilly and Company Latest Developments
Table 136. Jubilant Pharma Limited Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 137. Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 138. Jubilant Pharma Limited Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 139. Jubilant Pharma Limited Main Business
Table 140. Jubilant Pharma Limited Latest Developments
Table 141. Navidea Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 142. Navidea Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 143. Navidea Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 144. Navidea Main Business
Table 145. Navidea Latest Developments
Table 1. Nuclear Medicine Imaging Agents Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Nuclear Medicine Imaging Agents Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Fluorine 18 Labeling
Table 4. Major Players of Carbon 11 Labeling
Table 5. Major Players of Nitrogen 13 Labeling
Table 6. Major Players of Oxygen 15 Labeling
Table 7. Major Players of Technetium 99 Labeling
Table 8. Major Players of Others
Table 9. Global Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units)
Table 10. Global Nuclear Medicine Imaging Agents Sales Market Share by Type (2021-2026)
Table 11. Global Nuclear Medicine Imaging Agents Revenue by Type (2021-2026) & ($ million)
Table 12. Global Nuclear Medicine Imaging Agents Revenue Market Share by Type (2021-2026)
Table 13. Global Nuclear Medicine Imaging Agents Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Global Nuclear Medicine Imaging Agents Sale by Application (2021-2026) & (K Units)
Table 15. Global Nuclear Medicine Imaging Agents Sale Market Share by Application (2021-2026)
Table 16. Global Nuclear Medicine Imaging Agents Revenue by Application (2021-2026) & ($ million)
Table 17. Global Nuclear Medicine Imaging Agents Revenue Market Share by Application (2021-2026)
Table 18. Global Nuclear Medicine Imaging Agents Sale Price by Application (2021-2026) & (US$/Unit)
Table 19. Global Nuclear Medicine Imaging Agents Sales by Company (2021-2026) & (K Units)
Table 20. Global Nuclear Medicine Imaging Agents Sales Market Share by Company (2021-2026)
Table 21. Global Nuclear Medicine Imaging Agents Revenue by Company (2021-2026) & ($ millions)
Table 22. Global Nuclear Medicine Imaging Agents Revenue Market Share by Company (2021-2026)
Table 23. Global Nuclear Medicine Imaging Agents Sale Price by Company (2021-2026) & (US$/Unit)
Table 24. Key Manufacturers Nuclear Medicine Imaging Agents Producing Area Distribution and Sales Area
Table 25. Players Nuclear Medicine Imaging Agents Products Offered
Table 26. Nuclear Medicine Imaging Agents Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Nuclear Medicine Imaging Agents Sales by Geographic Region (2021-2026) & (K Units)
Table 30. Global Nuclear Medicine Imaging Agents Sales Market Share Geographic Region (2021-2026)
Table 31. Global Nuclear Medicine Imaging Agents Revenue by Geographic Region (2021-2026) & ($ millions)
Table 32. Global Nuclear Medicine Imaging Agents Revenue Market Share by Geographic Region (2021-2026)
Table 33. Global Nuclear Medicine Imaging Agents Sales by Country/Region (2021-2026) & (K Units)
Table 34. Global Nuclear Medicine Imaging Agents Sales Market Share by Country/Region (2021-2026)
Table 35. Global Nuclear Medicine Imaging Agents Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Nuclear Medicine Imaging Agents Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Nuclear Medicine Imaging Agents Sales by Country (2021-2026) & (K Units)
Table 38. Americas Nuclear Medicine Imaging Agents Sales Market Share by Country (2021-2026)
Table 39. Americas Nuclear Medicine Imaging Agents Revenue by Country (2021-2026) & ($ millions)
Table 40. Americas Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units)
Table 41. Americas Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (K Units)
Table 42. APAC Nuclear Medicine Imaging Agents Sales by Region (2021-2026) & (K Units)
Table 43. APAC Nuclear Medicine Imaging Agents Sales Market Share by Region (2021-2026)
Table 44. APAC Nuclear Medicine Imaging Agents Revenue by Region (2021-2026) & ($ millions)
Table 45. APAC Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units)
Table 46. APAC Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (K Units)
Table 47. Europe Nuclear Medicine Imaging Agents Sales by Country (2021-2026) & (K Units)
Table 48. Europe Nuclear Medicine Imaging Agents Revenue by Country (2021-2026) & ($ millions)
Table 49. Europe Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units)
Table 50. Europe Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (K Units)
Table 51. Middle East & Africa Nuclear Medicine Imaging Agents Sales by Country (2021-2026) & (K Units)
Table 52. Middle East & Africa Nuclear Medicine Imaging Agents Revenue Market Share by Country (2021-2026)
Table 53. Middle East & Africa Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units)
Table 54. Middle East & Africa Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Nuclear Medicine Imaging Agents
Table 56. Key Market Challenges & Risks of Nuclear Medicine Imaging Agents
Table 57. Key Industry Trends of Nuclear Medicine Imaging Agents
Table 58. Nuclear Medicine Imaging Agents Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Nuclear Medicine Imaging Agents Distributors List
Table 61. Nuclear Medicine Imaging Agents Customer List
Table 62. Global Nuclear Medicine Imaging Agents Sales Forecast by Region (2027-2032) & (K Units)
Table 63. Global Nuclear Medicine Imaging Agents Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Americas Nuclear Medicine Imaging Agents Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Americas Nuclear Medicine Imaging Agents Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. APAC Nuclear Medicine Imaging Agents Sales Forecast by Region (2027-2032) & (K Units)
Table 67. APAC Nuclear Medicine Imaging Agents Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Europe Nuclear Medicine Imaging Agents Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Europe Nuclear Medicine Imaging Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Middle East & Africa Nuclear Medicine Imaging Agents Sales Forecast by Country (2027-2032) & (K Units)
Table 71. Middle East & Africa Nuclear Medicine Imaging Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. Global Nuclear Medicine Imaging Agents Sales Forecast by Type (2027-2032) & (K Units)
Table 73. Global Nuclear Medicine Imaging Agents Revenue Forecast by Type (2027-2032) & ($ millions)
Table 74. Global Nuclear Medicine Imaging Agents Sales Forecast by Application (2027-2032) & (K Units)
Table 75. Global Nuclear Medicine Imaging Agents Revenue Forecast by Application (2027-2032) & ($ millions)
Table 76. GE HealthCare Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 77. GE HealthCare Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 78. GE HealthCare Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 79. GE HealthCare Main Business
Table 80. GE HealthCare Latest Developments
Table 81. Bracco Diagnostic Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 82. Bracco Diagnostic Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 83. Bracco Diagnostic Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. Bracco Diagnostic Main Business
Table 85. Bracco Diagnostic Latest Developments
Table 86. Guerbet Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 87. Guerbet Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 88. Guerbet Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Guerbet Main Business
Table 90. Guerbet Latest Developments
Table 91. Mallinckrodt Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 92. Mallinckrodt Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 93. Mallinckrodt Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Mallinckrodt Main Business
Table 95. Mallinckrodt Latest Developments
Table 96. Lantheus Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 97. Lantheus Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 98. Lantheus Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Lantheus Main Business
Table 100. Lantheus Latest Developments
Table 101. Yantai Dongcheng Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 102. Yantai Dongcheng Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 103. Yantai Dongcheng Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Yantai Dongcheng Main Business
Table 105. Yantai Dongcheng Latest Developments
Table 106. Foshan Rui Diao Pharmaceutical Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 107. Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 108. Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Foshan Rui Diao Pharmaceutical Main Business
Table 110. Foshan Rui Diao Pharmaceutical Latest Developments
Table 111. Cardinal Health Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 112. Cardinal Health Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 113. Cardinal Health Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Cardinal Health Main Business
Table 115. Cardinal Health Latest Developments
Table 116. Blue Earth Diagnostics Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 117. Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 118. Blue Earth Diagnostics Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Blue Earth Diagnostics Main Business
Table 120. Blue Earth Diagnostics Latest Developments
Table 121. Bayer AG Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 122. Bayer AG Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 123. Bayer AG Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Bayer AG Main Business
Table 125. Bayer AG Latest Developments
Table 126. Abx Advanced Biochemical Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 127. Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 128. Abx Advanced Biochemical Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. Abx Advanced Biochemical Main Business
Table 130. Abx Advanced Biochemical Latest Developments
Table 131. Eli Lilly and Company Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 132. Eli Lilly and Company Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 133. Eli Lilly and Company Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. Eli Lilly and Company Main Business
Table 135. Eli Lilly and Company Latest Developments
Table 136. Jubilant Pharma Limited Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 137. Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 138. Jubilant Pharma Limited Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 139. Jubilant Pharma Limited Main Business
Table 140. Jubilant Pharma Limited Latest Developments
Table 141. Navidea Basic Information, Nuclear Medicine Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 142. Navidea Nuclear Medicine Imaging Agents Product Portfolios and Specifications
Table 143. Navidea Nuclear Medicine Imaging Agents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 144. Navidea Main Business
Table 145. Navidea Latest Developments
LIST OF FIGURES
Figure 1. Picture of Nuclear Medicine Imaging Agents
Figure 2. Nuclear Medicine Imaging Agents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nuclear Medicine Imaging Agents Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Nuclear Medicine Imaging Agents Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Nuclear Medicine Imaging Agents Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Nuclear Medicine Imaging Agents Sales Market Share by Country/Region (2025)
Figure 10. Nuclear Medicine Imaging Agents Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Fluorine 18 Labeling
Figure 12. Product Picture of Carbon 11 Labeling
Figure 13. Product Picture of Nitrogen 13 Labeling
Figure 14. Product Picture of Oxygen 15 Labeling
Figure 15. Product Picture of Technetium 99 Labeling
Figure 16. Product Picture of Others
Figure 17. Global Nuclear Medicine Imaging Agents Sales Market Share by Type in 2026
Figure 18. Global Nuclear Medicine Imaging Agents Revenue Market Share by Type (2021-2026)
Figure 19. Nuclear Medicine Imaging Agents Consumed in Early Diagnosis
Figure 20. Global Nuclear Medicine Imaging Agents Market: Early Diagnosis (2021-2026) & (K Units)
Figure 21. Nuclear Medicine Imaging Agents Consumed in Clinical Stage
Figure 22. Global Nuclear Medicine Imaging Agents Market: Clinical Stage (2021-2026) & (K Units)
Figure 23. Nuclear Medicine Imaging Agents Consumed in Treatment Evaluation
Figure 24. Global Nuclear Medicine Imaging Agents Market: Treatment Evaluation (2021-2026) & (K Units)
Figure 25. Global Nuclear Medicine Imaging Agents Sale Market Share by Application (2025)
Figure 26. Global Nuclear Medicine Imaging Agents Revenue Market Share by Application in 2026
Figure 27. Nuclear Medicine Imaging Agents Sales by Company in 2026 (K Units)
Figure 28. Global Nuclear Medicine Imaging Agents Sales Market Share by Company in 2026
Figure 29. Nuclear Medicine Imaging Agents Revenue by Company in 2026 ($ millions)
Figure 30. Global Nuclear Medicine Imaging Agents Revenue Market Share by Company in 2026
Figure 31. Global Nuclear Medicine Imaging Agents Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Nuclear Medicine Imaging Agents Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Nuclear Medicine Imaging Agents Sales 2021-2026 (K Units)
Figure 34. Americas Nuclear Medicine Imaging Agents Revenue 2021-2026 ($ millions)
Figure 35. APAC Nuclear Medicine Imaging Agents Sales 2021-2026 (K Units)
Figure 36. APAC Nuclear Medicine Imaging Agents Revenue 2021-2026 ($ millions)
Figure 37. Europe Nuclear Medicine Imaging Agents Sales 2021-2026 (K Units)
Figure 38. Europe Nuclear Medicine Imaging Agents Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Nuclear Medicine Imaging Agents Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa Nuclear Medicine Imaging Agents Revenue 2021-2026 ($ millions)
Figure 41. Americas Nuclear Medicine Imaging Agents Sales Market Share by Country in 2026
Figure 42. Americas Nuclear Medicine Imaging Agents Revenue Market Share by Country (2021-2026)
Figure 43. Americas Nuclear Medicine Imaging Agents Sales Market Share by Type (2021-2026)
Figure 44. Americas Nuclear Medicine Imaging Agents Sales Market Share by Application (2021-2026)
Figure 45. United States Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Nuclear Medicine Imaging Agents Sales Market Share by Region in 2026
Figure 50. APAC Nuclear Medicine Imaging Agents Revenue Market Share by Region (2021-2026)
Figure 51. APAC Nuclear Medicine Imaging Agents Sales Market Share by Type (2021-2026)
Figure 52. APAC Nuclear Medicine Imaging Agents Sales Market Share by Application (2021-2026)
Figure 53. China Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 57. India Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Nuclear Medicine Imaging Agents Sales Market Share by Country in 2026
Figure 61. Europe Nuclear Medicine Imaging Agents Revenue Market Share by Country (2021-2026)
Figure 62. Europe Nuclear Medicine Imaging Agents Sales Market Share by Type (2021-2026)
Figure 63. Europe Nuclear Medicine Imaging Agents Sales Market Share by Application (2021-2026)
Figure 64. Germany Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 65. France Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Nuclear Medicine Imaging Agents Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Nuclear Medicine Imaging Agents Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Nuclear Medicine Imaging Agents Sales Market Share by Application (2021-2026)
Figure 72. Egypt Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Nuclear Medicine Imaging Agents in 2026
Figure 78. Manufacturing Process Analysis of Nuclear Medicine Imaging Agents
Figure 79. Industry Chain Structure of Nuclear Medicine Imaging Agents
Figure 80. Channels of Distribution
Figure 81. Global Nuclear Medicine Imaging Agents Sales Market Forecast by Region (2027-2032)
Figure 82. Global Nuclear Medicine Imaging Agents Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Nuclear Medicine Imaging Agents Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Nuclear Medicine Imaging Agents Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Nuclear Medicine Imaging Agents Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Nuclear Medicine Imaging Agents Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Nuclear Medicine Imaging Agents
Figure 2. Nuclear Medicine Imaging Agents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nuclear Medicine Imaging Agents Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Nuclear Medicine Imaging Agents Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Nuclear Medicine Imaging Agents Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Nuclear Medicine Imaging Agents Sales Market Share by Country/Region (2025)
Figure 10. Nuclear Medicine Imaging Agents Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Fluorine 18 Labeling
Figure 12. Product Picture of Carbon 11 Labeling
Figure 13. Product Picture of Nitrogen 13 Labeling
Figure 14. Product Picture of Oxygen 15 Labeling
Figure 15. Product Picture of Technetium 99 Labeling
Figure 16. Product Picture of Others
Figure 17. Global Nuclear Medicine Imaging Agents Sales Market Share by Type in 2026
Figure 18. Global Nuclear Medicine Imaging Agents Revenue Market Share by Type (2021-2026)
Figure 19. Nuclear Medicine Imaging Agents Consumed in Early Diagnosis
Figure 20. Global Nuclear Medicine Imaging Agents Market: Early Diagnosis (2021-2026) & (K Units)
Figure 21. Nuclear Medicine Imaging Agents Consumed in Clinical Stage
Figure 22. Global Nuclear Medicine Imaging Agents Market: Clinical Stage (2021-2026) & (K Units)
Figure 23. Nuclear Medicine Imaging Agents Consumed in Treatment Evaluation
Figure 24. Global Nuclear Medicine Imaging Agents Market: Treatment Evaluation (2021-2026) & (K Units)
Figure 25. Global Nuclear Medicine Imaging Agents Sale Market Share by Application (2025)
Figure 26. Global Nuclear Medicine Imaging Agents Revenue Market Share by Application in 2026
Figure 27. Nuclear Medicine Imaging Agents Sales by Company in 2026 (K Units)
Figure 28. Global Nuclear Medicine Imaging Agents Sales Market Share by Company in 2026
Figure 29. Nuclear Medicine Imaging Agents Revenue by Company in 2026 ($ millions)
Figure 30. Global Nuclear Medicine Imaging Agents Revenue Market Share by Company in 2026
Figure 31. Global Nuclear Medicine Imaging Agents Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Nuclear Medicine Imaging Agents Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Nuclear Medicine Imaging Agents Sales 2021-2026 (K Units)
Figure 34. Americas Nuclear Medicine Imaging Agents Revenue 2021-2026 ($ millions)
Figure 35. APAC Nuclear Medicine Imaging Agents Sales 2021-2026 (K Units)
Figure 36. APAC Nuclear Medicine Imaging Agents Revenue 2021-2026 ($ millions)
Figure 37. Europe Nuclear Medicine Imaging Agents Sales 2021-2026 (K Units)
Figure 38. Europe Nuclear Medicine Imaging Agents Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Nuclear Medicine Imaging Agents Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa Nuclear Medicine Imaging Agents Revenue 2021-2026 ($ millions)
Figure 41. Americas Nuclear Medicine Imaging Agents Sales Market Share by Country in 2026
Figure 42. Americas Nuclear Medicine Imaging Agents Revenue Market Share by Country (2021-2026)
Figure 43. Americas Nuclear Medicine Imaging Agents Sales Market Share by Type (2021-2026)
Figure 44. Americas Nuclear Medicine Imaging Agents Sales Market Share by Application (2021-2026)
Figure 45. United States Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Nuclear Medicine Imaging Agents Sales Market Share by Region in 2026
Figure 50. APAC Nuclear Medicine Imaging Agents Revenue Market Share by Region (2021-2026)
Figure 51. APAC Nuclear Medicine Imaging Agents Sales Market Share by Type (2021-2026)
Figure 52. APAC Nuclear Medicine Imaging Agents Sales Market Share by Application (2021-2026)
Figure 53. China Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 57. India Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Nuclear Medicine Imaging Agents Sales Market Share by Country in 2026
Figure 61. Europe Nuclear Medicine Imaging Agents Revenue Market Share by Country (2021-2026)
Figure 62. Europe Nuclear Medicine Imaging Agents Sales Market Share by Type (2021-2026)
Figure 63. Europe Nuclear Medicine Imaging Agents Sales Market Share by Application (2021-2026)
Figure 64. Germany Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 65. France Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Nuclear Medicine Imaging Agents Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Nuclear Medicine Imaging Agents Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Nuclear Medicine Imaging Agents Sales Market Share by Application (2021-2026)
Figure 72. Egypt Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Nuclear Medicine Imaging Agents Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Nuclear Medicine Imaging Agents in 2026
Figure 78. Manufacturing Process Analysis of Nuclear Medicine Imaging Agents
Figure 79. Industry Chain Structure of Nuclear Medicine Imaging Agents
Figure 80. Channels of Distribution
Figure 81. Global Nuclear Medicine Imaging Agents Sales Market Forecast by Region (2027-2032)
Figure 82. Global Nuclear Medicine Imaging Agents Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Nuclear Medicine Imaging Agents Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Nuclear Medicine Imaging Agents Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Nuclear Medicine Imaging Agents Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Nuclear Medicine Imaging Agents Revenue Market Share Forecast by Application (2027-2032)
